Menopause: Get the Facts and Get Talking
Recently, more and more women have been turning to Vivelle-Dot®. The smallest estrogen therapy (ET) patch available, it is used to relieve moderate to severe hot flashes, night sweats and vaginal dryness and atrophy associated with menopause. As you journey through menopause, Vivelle-Dot is by your side.
Menopause: Changes & Choices
Learn more about what you can expect during menopause.
Hysterectomy Center
If your doctor has recommended a hysterectomy with removal of your ovaries, there's a lot to consider, including your body's immediate transition into menopause. Learn more about this change, as well as the different types of procedures available.
Vivelle-Dot® Transdermal Patch
If you're considering ET, learn more about how Vivelle-Dot, the #1 prescribed ET patch, helps relieve moderate to severe hot flashes, night sweats and vaginal dryness and atrophy associated with menopause.
Doc & Diva: Conversations, Laughs and Information about Menopause
Keep your eyes on the monitor as two of the best menopause tour guides around prepare you for your journey. Join them now.
Estrogen Therapy: Options and Benefits
Some ET options can reduce your risk of osteoporosis (thin, weak bones). Learn more about your ET options.
Indication
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
Important Safety Information
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
Click here for the Full Prescribing Information for Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
The information contained within this Web site is appropriate for U.S. residents only. A visit to this site should not replace a visit to your doctor.
Available by prescription only.
Copyright ©2009 Novogyne Pharmaceuticals. All rights reserved.
WebMD does not endorse any specific product, service, or treatment.
